why choose us

First received: July 22, 2024

Clinical Trial: Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Recurrent C. Difficile Infection

Study Type: OBSERVATIONAL


Official Title: Efficacy Fo Oral Capsule FMT Combined with Bezlotoxumab Following Initial Failure of FMT Alone

Brief Summary: The goal is to evaluate the benefit of adding bezlotoxumab to repeat fecal microbiota transplantation (FMT) in patients with recurrent Clostridioides difficile infections after failure of FMT alone.

Read more